Classifieds | Archives | Jobs | About TGT | Contact | Subscribe
 | 
Last updated 18 minutes ago
Printer Friendly Version | TGT@Twitter | RSS Feed |
HOME LOCAL MIDEAST ASIA WORLD BUSINESS SPORT OPINION WRITERS
Froome admits adverse test result ‘damaging’
December 15, 2017
 Print    Send to Friend

London: Chris Froome admitted on Thursday that his adverse drugs test during his victory at the Vuelta a Espana is “damaging” as the four-time Tour de France winner battles to clear his name.

The British rider had twice the permissible amount of asthma medication Salbutamol in his system during the Grand Tour race he won in September. Cycling’s governing body UCI has asked the Team Sky rider to provide more information but in line with World Anti-Doping Agency guidelines has not suspended him.

If Froome fails to provide a satisfactory answer the UCI could proceed with an anti-doping rule violation case, which could strip him of his Vuelta victory and result in him missing a large chunk of next season.

“This is damaging. It’s come as a huge shock to me as well,” Froome, 32, told Sky Sports.

“At the same time I know within me that fundamentally I have followed the protocol, I have not overstepped any boundaries and I hope by the end of this process that will be clear to everyone and I’ll be exonerated of any wrongdoing.

Team Sky said in a statement on Wednesday that Froome experienced “acute asthma symptoms” during the final week of the Vuelta and increased his dosage of Salbutamol, within permissible limits, on medical advice.

“Coming into the last week of La Vuelta I began to feel a lot more symptomatic -- my asthma was playing up a lot more and that’s when the doctor advised me to increase the number of puffs - obviously staying well in the legal limit of the maximum allowed number of puffs you can take during the race,” said Froome.

“So we did increase it and that’s why we’re faced with this question of ‘I did stay within the limits but obviously the test results show a different reading’ so we’re trying to evaluate what has happened.”

Movistar challenge

Movistar announced all three of Nairo Quintana, Alejandro Valverde and the newly recruited Mikel Landa will team up to ride the 2018 Tour de France on Thursday.

The team are considered as British team Sky’s closest rival ands the line up represents their strongest assault on the yellow jersey yet.

The Spanish outfit snapped up climb specialist Landa from Team Sky in August with the objective of ending Sky and Chris Froome’s grip on the Tour. However, Movistar’s task could be made much easier if Froome is sanctioned for an adverse drugs test result as he won the Vuelta a Espana in September.

Agence France-Presse

Add this page to your favorite Social Bookmarking websites
Comments
 
Post a comment
 
Name:
Country:
City:
Email:
Comment:
 
    
    
Related Stories
O’Connor wins Alps third stage, Froome sixth
Milan: Australian Ben O’Connor won the third stage of the Tour of the Alps on Wednesday with Britain’s four-time Tour de France winner Chris Froome finishing sixth. Di..
Goolaerts’ death casts pall on Amstel Gold race
Maastricht: Cycling’s spring classics roll into the Netherlands on Sunday with a powerful cast of pretenders in the Amstel Gold Race where champion Philippe Gilbert will ..
Admin blunder shatters dreams of English cyclist
Gold Coast: An English road cyclist said she was “gutted” on Tuesday after her Commonwealth Games dreams were shattered because team officials failed to register her for ..
Cycling world mourns death of 23-year-old Goolaerts
Paris: The world of cycling on Monday mourned Belgian cyclist Michael Goolaerts after he died of heart failure at the age of 23 during the gruelling Paris-Roubaix one-day..
Sagan wins Paris-Roubaix cycling classic
Roubaix: World champion Peter Sagan left his rivals in the dust on Sunday after a break from 55km out saw him clinch a jaw dropping victory in the 257km Paris-Roubaix cla..
FRONTPAGE
 
GALLERY
 
PANORAMA
 
TIME OUT
 
SPORT
 
 
Advertise | Copyright